A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: One of the main challenges for drug evaluation in rare diseases is the often heterogeneous course of these diseases. Traditional outcome measures may not be applicable for all patients, when they are in different stages of their disease. For instance, in Duchenne Muscular Dystrophy, the Six Minute Walk Test is often used to evaluate potential new treatments, whereas this outcome is irrelevant for patients who are already in a wheelchair. A measurement instrument such as Goal Attainment Scaling (GAS) can evaluate the effect of an intervention on an individual basis, and may be able to include patients even when they are in different stages of their disease. It allows patients to set individual goals, together with their treating professional. However, the validity of GAS as a measurement instrument in drug studies has never been systematically reviewed. Therefore, we have performed a systematic review to answer two questions: 1. Has GAS been used as a measurement instrument in drug studies? 2: What is known of the validity, responsiveness and inter- and intra-rater reliability of GAS, particularly in drug trials? METHODS: We set up a sensitive search that yielded 3818 abstracts. After careful screening, data-extraction was executed for 58 selected articles. RESULTS: Of the 58 selected articles, 38 articles described drug studies where GAS was used as an outcome measure, and 20 articles described measurement properties of GAS in other settings. The results show that validity, responsiveness and reliability of GAS in drug studies have hardly been investigated. The quality of the reporting of validity in studies in which GAS was used to evaluate a non-drug intervention also leaves much room for improvement. CONCLUSIONS: We conclude that there is insufficient information to assess the validity of GAS, due to the poor quality of the validity studies. Therefore, we think that GAS needs further validation in drug studies, especially since GAS can be a potential solution when a small heterogeneous patient group is all there is to test a promising new drug. TRIAL REGISTRATION: The protocol has been registered in the PROSPERO international prospective register for systematic reviews, with registration number CRD42014010619. http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014010619 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quality criteria were proposed for measurement properties of health status questionnaires
Terwee, C. B., Bot, S. D. M., de Boer, M. R., van der Windt, D. A. W. M., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. W. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.03.012 · Cited by 10,764 · cited 2×
“[19] to evaluate the measurement properties, as also displayed in Table 1.”
MethodMokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., Bouter, L. M., & de Vet, H. C. W. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.02.006 · Cited by 4,465 · cited 1×
“urement properties, defined according to the COSMIN guidelines [18]: Inter-rater reliability, intra-rater reliabil-”
MethodMokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., Bouter, L. M., & de Vet, H. C. W. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9606-8 · Cited by 4,260 · cited 1×
“In this study, we follow the COSMIN guidelines, which are the generally used and accepted standards for measurement properties evaluation [16].”
MethodMeasurement in Medicine: A Practical Guide
de Vet, H. C. W., Terwee, C. B., Mokkink, L. B., & Knol, D. L. (2011) · doi:10.1017/cbo9780511996214 · Cited by 2,321
Goal attainment scaling: An idiosyncratic method to assess treatment effectiveness in agoraphobia
de Beurs, E., Lange, A., Blonk, R. W. B., Koele, P., van Balkom, A. J. L. M., & Van Dyck, R. (1993) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/bf00965038 · Cited by 16 · cited 6×
“+/− No hypotheses De Beurs 1993 Yes 40 Correlations with agoraphobia, rating of treatment outcome by therapist, M-BAT, depression and somatic anxiety were measured; GAS has a high correlation with gain scores on agoraphobia (0.63), rating of treatment outcome by therapist (0.43), and M-BAT (0.57).”
BackgroundMethodInfluential
Cited by
Boxer, A. L., Gold, M., Feldman, H., Boeve, B. F., Dickinson, S. L.-J., Fillit, H., Ho, C., Paul, R., Pearlman, R., Sutherland, M., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4956 · Cited by 71
Bard-Pondarré, R., Villepinte, C., Roumenoff, F., Lebrault, H., Bonnyaud, C., Pradeau, C., Bensmail, D., Isner-Horobeti, M.-E., & Krasny-Pacini, A. (2023) · Journal of Rehabilitation Medicine · doi:10.2340/jrm.v55.6498 · Cited by 56
Smits, A., Annaert, P., Cavallaro, G., De Cock, P. A. J. G., de Wildt, S. N., Kindblom, J. M., Lagler, F. B., Moreno, C., Pokorna, P., Schreuder, M. F., et al. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14958 · Cited by 55
“Clinical trial endpoints can be optimized by modelling natural history data (registries),(140) fallback tests for coprimary endpoints,(141) and goal attainment scaling.(142) Confirmatory”
BackgroundMcCue, M., Sarkey, S., Eramo, A., François, C., & Parikh, S. V. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03608-1 · Cited by 15
Metadata
- Authors
- Gaasterland, C. M. W., Jansen-van der Weide, M. C., Weinreich, S. S., & van der Lee, J. H.
- Venue
- BMC Medical Research Methodology
- Published
- 2016-08-17
- Volume
- 16
- Issue
- 1
- Pages
- 99-99
- ISSN
- 1471-2288 (ISSN-L)
- OpenAlex
- W2512421561
- Cited by
- 59
- References
- 5
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials. https://app.cochat.ai/papers/10.1186/s12874-016-0205-4
- The paper
- Gaasterland, C. M. W., Jansen-van der Weide, M. C., Weinreich, S. S., & van der Lee, J. H. (2016). A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials. BMC Medical Research Methodology. https://doi.org/10.1186/s12874-016-0205-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.